Head-to-head comparison of 7 high-sensitive human papillomavirus nucleic acid detection technologies with the SPF10 LiPA-25 system

Zhang, 2021, Cancer incidence and mortality in China, 2015, Journal of National Cancer Center, 1, 2, 10.1016/j.jncc.2020.12.001 Zhao, 2019, Cervical cancer prevention in China: a key to cancer control, Lancet, 393, 969, 10.1016/S0140-6736(18)32849-6 Choi, 2016, Clinical significance of human papillomavirus genotyping, J Gynecol Oncol, 27, e21, 10.3802/jgo.2016.27.e21 Sundstrom, 2010, Prospective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervix, Cancer Epidemiol Biomarkers Prev, 19, 2469, 10.1158/1055-9965.EPI-10-0424 Kjaer, 2002, Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study, BMJ, 325, 572, 10.1136/bmj.325.7364.572 de Sanjose, 2010, Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, 11, 1048, 10.1016/S1470-2045(10)70230-8 Stanley, 2010, Pathology and epidemiology of HPV infection in females, Gynecol Oncol, 117, S5, 10.1016/j.ygyno.2010.01.024 Small, 2017, Cervical cancer: A global health crisis, Cancer, 123, 2404, 10.1002/cncr.30667 Latsuzbaia, 2019, Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg, Cancer Epidemiol, 63, 10.1016/j.canep.2019.101593 Jacot-Guillarmod, 2017, Impact of HPV vaccination with Gardasil(R) in Switzerland, BMC Infect Dis, 17, 790, 10.1186/s12879-017-2867-x Latsuzbaia, 2016, Analytical performance evaluation of Anyplex II HPV28 and Euroarray HPV for genotyping of cervical samples, Diagn Microbiol Infect Dis, 85, 318, 10.1016/j.diagmicrobio.2016.04.011 van Hamont, 2006, Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test, J Clin Microbiol, 44, 3122, 10.1128/JCM.00517-06 Castle, 2008, Comparison of two PCR-based human papillomavirus genotyping methods, J Clin Microbiol, 46, 3437, 10.1128/JCM.00620-08 Herrero, 2011, Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica, Cancer Discov, 1, 408, 10.1158/2159-8290.CD-11-0131 Kreimer, 2011, Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial, Lancet Oncol, 12, 862, 10.1016/S1470-2045(11)70213-3 Lehtinen, 2012, Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial, Lancet Oncol, 13, 89, 10.1016/S1470-2045(11)70286-8 Wheeler, 2012, Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial, Lancet Oncol, 13, 100, 10.1016/S1470-2045(11)70287-X Hildesheim, 2014, Efficacy of the HPV-16/18 vaccine: final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial, Vaccine, 32, 5087, 10.1016/j.vaccine.2014.06.038 Qiao, 2020, Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial, J Natl Cancer Inst, 112, 145, 10.1093/jnci/djz074 Zhu, 2014, Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial, Int J Cancer, 135, 2612, 10.1002/ijc.28897 Alemany, 2014, Large contribution of human papillomavirus in vaginal neoplastic lesions: a worldwide study in 597 samples, Eur J Cancer, 50, 2846, 10.1016/j.ejca.2014.07.018 Schmeink, 2013, Prospective follow-up of 2,065 young unscreened women to study human papillomavirus incidence and clearance, Int J Cancer, 133, 172, 10.1002/ijc.27986 Geraets, 2015, The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra, J Virol Methods, 215-216, 22, 10.1016/j.jviromet.2015.01.001 Sun, 2015, Development of a fluorescence-based multiplex genotyping method for simultaneous determination of human papillomavirus infections and viral loads, BMC Cancer, 15, 860, 10.1186/s12885-015-1874-9 Else, 2011, Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay, J Clin Microbiol, 49, 1907, 10.1128/JCM.00236-10 Iftner, 2009, Study comparing human papillomavirus (HPV) real-time multiplex PCR and Hybrid Capture II INNO-LiPA v2 HPV genotyping PCR assays, J Clin Microbiol, 47, 2106, 10.1128/JCM.01907-08 van Alewijk, 2013, A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay, J Clin Microbiol, 51, 1171, 10.1128/JCM.02831-12 Estrade, 2014, Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping, J Clin Microbiol, 52, 607, 10.1128/JCM.02749-13 Hesselink, 2016, Clinical validation of Anyplex II HPV HR Detection according to the guidelines for HPV test requirements for cervical cancer screening, J Clin Virol, 76, 36, 10.1016/j.jcv.2016.01.009 Sun, 2017, Clinical validation of the PCR-reverse dot blot human papillomavirus genotyping test in cervical lesions from Chinese women in the Fujian province: a hospital-based population study, J Gynecol Oncol, 28, e50, 10.3802/jgo.2017.28.e50 Jiang, 2006, Genotyping of human papillomavirus in cervical lesions by L1 consensus PCR and the Luminex xMAP system, J Med Microbiol, 55, 715, 10.1099/jmm.0.46493-0 Zhao, 2017, Comparison of the cervista HPV HR test and luminex XMAP technology for the diagnosis of cervical intraepithelial neoplasia, Eur J Obstet Gynecol Reprod Biol, 214, 150, 10.1016/j.ejogrb.2017.05.012 Wagner, 2019, Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes, J Infect Dis, 220, 1609, 10.1093/infdis/jiz324 Fan, 2018, Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing, Dis Markers, 2018, 10.1155/2018/4826547 Tjalma, 2013, Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe, Int J Cancer, 132, 854, 10.1002/ijc.27713 van Doorn, 2002, Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay, J Clin Microbiol, 40, 979, 10.1128/JCM.40.3.979-983.2002 Zhou, 2018, Prevalence and distribution of human papillomavirus genotypes in Chinese women between 1991 and 2016: A systematic review, J Infect, 76, 522, 10.1016/j.jinf.2018.02.008 Chan, 2014, Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide, PLoS One, 9, 10.1371/journal.pone.0107573 Li, 2019, The distribution and prevalence of human papillomavirus in women in mainland China, Cancer, 125, 1030, 10.1002/cncr.32003 Clifford, 2003, Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis, Br J Cancer, 88, 63, 10.1038/sj.bjc.6600688 2014 Zhang, 2020, Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis, Arch Gynecol Obstet, 302, 1329, 10.1007/s00404-020-05787-w Baay, 1996, Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas, J Clin Microbiol, 34, 745, 10.1128/jcm.34.3.745-747.1996